MPIDB (formerly the Pediatric, Adolescent, and Maternal AIDS Branch) supports and conducts domestic and international research related to the epidemiology, diagnosis, clinical manifestations, pathogenesis, transmission, treatment, and prevention of HIV infection and its complications in infants, children, adolescents, and pregnant and nonpregnant women. As the HIV epidemic has evolved and other infectious diseases have emerged in the United States and globally, the branch has ensured that its funded research reflects these changes and addresses important research opportunities and gaps as they arise, including HIV-associated co-infections (such as tuberculosis, hepatitis, and malaria) in children and pregnant women. Furthermore, MPIDB supports and conducts research on the epidemiology, natural history, pathogenesis, transmission, treatment, and prevention of other significant infectious diseases, including congenital infections, such as Zika virus and cytomegalovirus; tropical diseases, specifically those that affect children and pregnant women; and vaccine-preventable disease in infants, children, adolescents, and women.
- NIH launches prospective study of Zika and HIV co-infection during pregnancy: MPIDB staff and investigators collaborate to determine the potential risks that infection with the Zika virus might pose for pregnancies.
- Collaborative HIV program improves long-term care for youths in the United States: MPIDB staff and investigators of the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) collaborated with the CDC and HRSA.
- NIH funds research network devoted to the health of adolescents with HIV or at risk for HIV infection: MPIDB leads the ATN to support research for youth in the United States.
- Global estimates on paediatric and adolescent HIV survival and death: NICHD supports the International Epidemiology Databases to Evaluate AIDS global consortium (IeDEA) in low- and middle-income countries to provide age-disaggregated data for modeling efforts.